Literature DB >> 25202660

Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience.

Haesun Choi1, Michelle Underwood1, Piyaporn Boonsirikamchai1, Surena Matin1, Patricia Troncoso1, Jingfei Ma1.   

Abstract

The magnetic resonance spectroscopic imaging (MRSI) is the only technique that is currently available in the clinical practice to provide the metabolic status of prostate tissue at the cellular level with a great potential to improve the clinical patient care. Increasing the field strength from 1.5 to 3 T can theoretically provide proportionately higher signal-to-noise ratio (SNR) and improve spectral separation between prostatic metabolite peaks. The technique, however, has been limited to a few academic institutions that are equipped with a team of experts primarily due to due to serious technical challenges in optimizing the spectral quality. High quality shimming is key to the successful MRSI acquisition. Without optimization of the increased field inhomogeneity and radiofrequency (RF) dielectric effect at 3 T, the spectral peak broadening and residual signal from the periprostatic fat tissue may render the overall spectra non-diagnostic. The purpose of this technical note is to present the practical steps of successful acquisition of 3 T MRSI and to address several important technical challenges in minimizing the effect of the increased magnetic field and RF field inhomogeneity in order to obtain highest possible spectral quality based on our initial experience in using 3 T MRSI prototype software.

Entities:  

Keywords:  3 T; Prostate cancer; magnetic field inhomogeneity; magnetic resonance spectroscopy; radiofrequency (RF) field inhomogeneity

Year:  2014        PMID: 25202660      PMCID: PMC4137178          DOI: 10.3978/j.issn.2223-4292.2014.07.09

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  12 in total

Review 1.  Magnetic resonance spectroscopic studies of the prostate.

Authors:  J A Koutcher; K Zakian; H Hricak
Journal:  Mol Urol       Date:  2000

Review 2.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

Authors:  Caroline M A Hoeks; Jelle O Barentsz; Thomas Hambrock; Derya Yakar; Diederik M Somford; Stijn W T P J Heijmink; Tom W J Scheenen; Pieter C Vos; Henkjan Huisman; Inge M van Oort; J Alfred Witjes; Arend Heerschap; Jurgen J Fütterer
Journal:  Radiology       Date:  2011-10       Impact factor: 11.105

Review 3.  The role of magnetic resonance imaging in the diagnosis and management of prostate cancer.

Authors:  James Thompson; Nathan Lawrentschuk; Mark Frydenberg; Les Thompson; Phillip Stricker
Journal:  BJU Int       Date:  2013-11       Impact factor: 5.588

Review 4.  Citrate metabolism of normal and malignant prostate epithelial cells.

Authors:  L C Costello; R B Franklin
Journal:  Urology       Date:  1997-07       Impact factor: 2.649

Review 5.  The potential role of perfluorochemicals (PFCs) in diagnostic imaging.

Authors:  R F Mattrey
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  1994

6.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study.

Authors:  J Scheidler; H Hricak; D B Vigneron; K K Yu; D L Sokolov; L R Huang; C J Zaloudek; S J Nelson; P R Carroll; J Kurhanewicz
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

7.  Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.

Authors:  Akihiro Tanimoto; Jun Nakashima; Hidaka Kohno; Hiroshi Shinmoto; Sachio Kuribayashi
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

8.  Use of perfluorocarbon compound in the endorectal coil to improve MR spectroscopy of the prostate.

Authors:  Haesun Choi; Jingfei Ma
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

Review 9.  Mapping of prostate cancer by 1H MRSI.

Authors:  Thiele Kobus; Alan J Wright; Tom W J Scheenen; Arend Heerschap
Journal:  NMR Biomed       Date:  2013-06-13       Impact factor: 4.044

Review 10.  Functional and molecular imaging of localized and recurrent prostate cancer.

Authors:  Kinzya Grant; Maria L Lindenberg; Haytham Shebel; Yuxi Pang; Harsh K Agarwal; Marcelino Bernardo; Karen A Kurdziel; Baris Turkbey; Peter L Choyke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

View more
  1 in total

Review 1.  Current role of multiparametric magnetic resonance imaging for prostate cancer.

Authors:  Romaric Loffroy; Olivier Chevallier; Morgan Moulin; Sylvain Favelier; Pierre-Yves Genson; Pierre Pottecher; Gilles Crehange; Alexandre Cochet; Luc Cormier
Journal:  Quant Imaging Med Surg       Date:  2015-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.